Augur Signals: News Feed

Report Archive – October 2023

Augur Signals: News Feed
Chemicals , Basic Materials , Alert

Insider Trading Alert: Donfeld Joshua Jay Buys ASP Isotopes Inc. Stock

  • Acquired: Non-Derivative
Insider Trading Alert: Donfeld Joshua Jay Buys ASP Isotopes Inc. Stock
On , Donfeld Joshua Jay, a director of ASP Isotopes Inc., purchased 104,167 shares of Common Stock, raising his total to 1,104,167 shares, valued at approximately $109,375.35. His involvement since suggests confidence in the company, despite a low P/E ratio of -40 and high P/B and P/S ratios of 13.81 and 143.05. The stock price was $1.05 on the transaction date, with a potential rise to $1.15 in the short term.
Farm Products , Consumer Defensive , Alert

Insider Trading Alert: Local Bounti Corporation

  • Acquired: Non-Derivative
Insider Trading Alert: Local Bounti Corporation
An insider transaction was reported on October 31, 2023 for Local Bounti Corporation by officer Fabrega Anna M., purchasing 18,801 shares. This marks her third transaction since May 2022. Her previous acquisition involved 2,750,000 shares, showing confidence in the company. The stock's closing price was $1.66, up from $1.24, with a spike in volume to 870,200. Valuation metrics suggest mixed signals, with a Price-to-Earnings Ratio of -0.27 and a Price-to-Sales Ratio of 0.46. The short-term outlook is bullish, with potential price targets of $1.80 to $2.10.
Internet Retail , Consumer Cyclical , Alert

Insider Trading Alert: Beyond, Inc.

  • Acquired: Non-Derivative
Insider Trading Alert: Beyond, Inc.
An insider trading alert was triggered for Beyond, Inc. (BYON) on October 27, 2023, involving Lemonis Marcus, a director and ten percent owner, purchasing 40,293 shares. This increased his total to 147,293 shares. The transaction date saw a closing price of $13.93, down from $15.40, with a trading volume of 3,673,500. Beyond, Inc. is trading with a P/E ratio of -3.96, indicating potential undervaluation. The 5-day RSI of 24.81 suggests an oversold condition. Price predictions indicate targets of $15.50 to $16.00 in the immediate term.
Banks—Regional , Financial Services , Alert

Insider Trading Alert: Arrow Financial Corporation

  • Acquired: Non-Derivative
Insider Trading Alert: Arrow Financial Corporation
On October 27, 2023, Behan Mark of Arrow Financial Corporation acquired 479 shares at $20.83 each, totaling $9,977.57. With a strong insider performance and an annualized ROI of 36.01%, Mark's purchase indicates confidence in the company's prospects. Despite certain overvaluation metrics, technical indicators suggest the stock price might rise to $22.00 in 5-10 days, potentially reaching $23.00 in 4 weeks, assuming stable market conditions.
Lodging , Consumer Cyclical , Alert

Insider Trading Alert: LuxUrban Hotels Inc. - A Strategic Move by Shanoop Kothari

  • Acquired: Non-Derivative
On October 26, 2023, Shanoop Kothari of LuxUrban Hotels Inc. purchased 20,000 shares of 13.00% Series A Cumulative Redeemable Preferred Stock for about $79,800. This transaction suggests potential undervaluation given the company's low P/E and P/S ratios. The stock price is expected to rise to $4.20–$4.30 in the short term, with further potential up to $4.60 over four weeks, assuming stable market conditions.
Consulting Services , Industrials , Alert

Insider Trading Alert: Equifax Inc. - A Strategic Move or Overvaluation?

  • Acquired: Non-Derivative
Insider Trading Alert: Equifax Inc. - A Strategic Move or Overvaluation?
On October 26, 2023, Smith Melissa D, a director at Equifax Inc., bought 914 shares valued at $151,888.51. Her investment aligns with her strategic behavior, hinting at potential growth or undervaluation. Currently, Equifax Inc. trades at a high P/E ratio of 35.08, indicating overvaluation risks. Despite this, the RSI suggests the stock might be oversold, potentially attracting buyers. Investors should watch market reactions and announcements closely.
Other Precious Metals & Mining , Basic Materials , Alert

Insider Trading Alert: Analyzing the Implications for Comstock Inc.

  • Acquired: Non-Derivative
Insider Trading Alert: Analyzing the Implications for Comstock Inc.
On October 27, 2023, William Joseph McCarthy, an officer at Comstock Inc., purchased 25,500 shares of Common Stock for $10,200, increasing his holdings to 1,527,000 shares. His past transactions have shown a 32.5% ROI over four weeks and 52.5% over sixteen weeks. Comstock Inc., operating in the Basic Materials sector, has a negative P/E ratio of -3.97 and a P/B ratio of 1.09. Despite a high P/S ratio of 40.3, insider confidence suggests potential undervaluation. Technical indicators imply a possible price rebound, with short-term price targets of $0.42 and $0.45.
REIT—Diversified , Real Estate , Alert

Insider Trading Alert: Presidio Property Trust, Inc.

  • Acquired: Non-Derivative
Insider Trading Alert: Presidio Property Trust, Inc.
On , Heilbron Jack Kendrick, a director at Presidio Property Trust, Inc., purchased 100 shares of Preferred Stock - Series D - SQFTP at $0.55 each, totaling $55.00. His active involvement, with 52 transactions this year, reflects deep company insight. Despite a declining stock trend, with a recent close at $0.54, the stock's low P/B and P/S ratios suggest undervaluation. A projected short-term price rise to $0.62 is anticipated, driven by insider confidence and market dynamics.
Biotechnology , Healthcare , Alert

Insider Trading Alert: A Detailed Analysis of Sonnet BioTherapeutics

  • Acquired: Non-Derivative
Insider Trading Alert: A Detailed Analysis of Sonnet BioTherapeutics
On October 27, 2023, an insider trading alert was triggered for Sonnet BioTherapeutics Holdings, Inc. (SONN) in the Biotechnology industry. Mohan Pankaj, a director, purchased 34,375 shares, raising his total to 59,526 shares, valued at approximately $39,531.25. Traded at $9.20 per share, the transaction suggests potential undervaluation, as indicated by a low P/E ratio of -0.18 and high P/S ratio of 39.42. Market indicators predict a short-term target price of $9.50 to $11.00.
Biotechnology , Healthcare , Alert

Insider Trading Alert: Talaris Therapeutics, Inc.

  • Acquired: Non-Derivative

On October 25, 2023, an insider transaction was recorded for Talaris Therapeutics, Inc. on the Nasdaq NMS. Castelein Caley, a director, purchased 20,000 shares of common stock at $12.36 per share, totaling approximately $213,000. Castelein Caley has been with the company since September 13, 2016, conducting 53 insider transactions. The healthcare sector, particularly biotechnology, has seen fluctuations, with Talaris showing potential growth despite a negative P/E ratio of -6.22. The share price may increase modestly in the short term, potentially reaching $13.00 - $13.50 and stabilizing between $14.00 - $15.00 in the coming weeks.

Back

Pages total: 3

Calendar